Selected research
Market Structure
Global Porcine Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Porcine Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Porcine Medicine and Vaccines include Merck, Jinyu Bio-Technology, ChengDu Tecbond, Zoetis, WINSUN, Virbac, Tecon, Ringpu Biology and HVRI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Porcine Medicine and Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Porcine Medicine and Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Porcine Medicine and Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Porcine Medicine and Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Porcine Medicine and Vaccines Segment by Company
Merck
Jinyu Bio-Technology
ChengDu Tecbond
Zoetis
WINSUN
Virbac
Tecon
Ringpu Biology
HVRI
Hipra
Hile Bio
DHN
Chopper Biology
Ceva
CAVAC
CAHIC
Boehringer Ingelheim
Bioveta
Porcine Medicine and Vaccines Segment by Type
Medicine
Vaccines
Porcine Medicine and Vaccines Segment by Application
Government Tender
Market Sales
Porcine Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Porcine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Porcine Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Porcine Medicine and Vaccines industry.
Chapter 3: Detailed analysis of Porcine Medicine and Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Medicine and Vaccinesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Government Tender
- Market Sales
Companies covered
- Merck
- Jinyu Bio-Technology
- ChengDu Tecbond
- Zoetis
- WINSUN
- Virbac
- Tecon
- Ringpu Biology
- HVRI
- Hipra
- Hile Bio
- DHN
- Chopper Biology
- Ceva
- CAVAC
- CAHIC
- Boehringer Ingelheim
- Bioveta
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Porcine Medicine and Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Medicine
- 1.2.3 Vaccines
- 1.3 Market Analysis by Application
- 1.3.1 Global Porcine Medicine and Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Government Tender
- 1.3.3 Market Sales
- 1.4 Global Market Growth Prospects
- 1.5 Global Porcine Medicine and Vaccines Growth Trends by Region
- 1.5.1 Global Porcine Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Porcine Medicine and Vaccines Market Size by Region (2021-2026)
- 1.5.3 Porcine Medicine and Vaccines Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Porcine Medicine and Vaccines Market Dynamics
- 2.1 Porcine Medicine and Vaccines Industry Trends
- 2.2 Porcine Medicine and Vaccines Industry Drivers
- 2.3 Porcine Medicine and Vaccines Industry Opportunities and Challenges
- 2.4 Porcine Medicine and Vaccines Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Porcine Medicine and Vaccines Revenue by Company (2021-2026)
- 3.2 Global Porcine Medicine and Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Porcine Medicine and Vaccines Key Company Head office and Area Served
- 3.4 Global Porcine Medicine and Vaccines Company, Product Type & Application
- 3.5 Global Porcine Medicine and Vaccines Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Porcine Medicine and Vaccines Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Porcine Medicine and Vaccines Players Market Share by Revenue in 2025
- 3.6.3 2025 Porcine Medicine and Vaccines Tier 1, Tier 2, and Tier 3
4 Porcine Medicine and Vaccines Market by Type
- 4.1 Global Porcine Medicine and Vaccines Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Porcine Medicine and Vaccines Market Size by Type (2021-2032)
- 4.3 Global Porcine Medicine and Vaccines Market Size Share by Type (2021-2032)
5 Porcine Medicine and Vaccines Market by Application
- 5.1 Global Porcine Medicine and Vaccines Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Porcine Medicine and Vaccines Market Size by Application (2021-2032)
- 5.3 Global Porcine Medicine and Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck Porcine Medicine and Vaccines Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Jinyu Bio-Technology
- 6.2.1 Jinyu Bio-Technology Company Information
- 6.2.2 Jinyu Bio-Technology Business Overview
- 6.2.3 Jinyu Bio-Technology Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio
- 6.2.5 Jinyu Bio-Technology Recent Developments
- 6.3 ChengDu Tecbond
- 6.3.1 ChengDu Tecbond Company Information
- 6.3.2 ChengDu Tecbond Business Overview
- 6.3.3 ChengDu Tecbond Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio
- 6.3.5 ChengDu Tecbond Recent Developments
- 6.4 Zoetis
- 6.4.1 Zoetis Company Information
- 6.4.2 Zoetis Business Overview
- 6.4.3 Zoetis Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Zoetis Porcine Medicine and Vaccines Product Portfolio
- 6.4.5 Zoetis Recent Developments
- 6.5 WINSUN
- 6.5.1 WINSUN Company Information
- 6.5.2 WINSUN Business Overview
- 6.5.3 WINSUN Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 WINSUN Porcine Medicine and Vaccines Product Portfolio
- 6.5.5 WINSUN Recent Developments
- 6.6 Virbac
- 6.6.1 Virbac Company Information
- 6.6.2 Virbac Business Overview
- 6.6.3 Virbac Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Virbac Porcine Medicine and Vaccines Product Portfolio
- 6.6.5 Virbac Recent Developments
- 6.7 Tecon
- 6.7.1 Tecon Company Information
- 6.7.2 Tecon Business Overview
- 6.7.3 Tecon Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Tecon Porcine Medicine and Vaccines Product Portfolio
- 6.7.5 Tecon Recent Developments
- 6.8 Ringpu Biology
- 6.8.1 Ringpu Biology Company Information
- 6.8.2 Ringpu Biology Business Overview
- 6.8.3 Ringpu Biology Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Ringpu Biology Porcine Medicine and Vaccines Product Portfolio
- 6.8.5 Ringpu Biology Recent Developments
- 6.9 HVRI
- 6.9.1 HVRI Company Information
- 6.9.2 HVRI Business Overview
- 6.9.3 HVRI Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 HVRI Porcine Medicine and Vaccines Product Portfolio
- 6.9.5 HVRI Recent Developments
- 6.10 Hipra
- 6.10.1 Hipra Company Information
- 6.10.2 Hipra Business Overview
- 6.10.3 Hipra Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Hipra Porcine Medicine and Vaccines Product Portfolio
- 6.10.5 Hipra Recent Developments
- 6.11 Hile Bio
- 6.11.1 Hile Bio Company Information
- 6.11.2 Hile Bio Business Overview
- 6.11.3 Hile Bio Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Hile Bio Porcine Medicine and Vaccines Product Portfolio
- 6.11.5 Hile Bio Recent Developments
- 6.12 DHN
- 6.12.1 DHN Company Information
- 6.12.2 DHN Business Overview
- 6.12.3 DHN Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 DHN Porcine Medicine and Vaccines Product Portfolio
- 6.12.5 DHN Recent Developments
- 6.13 Chopper Biology
- 6.13.1 Chopper Biology Company Information
- 6.13.2 Chopper Biology Business Overview
- 6.13.3 Chopper Biology Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Chopper Biology Porcine Medicine and Vaccines Product Portfolio
- 6.13.5 Chopper Biology Recent Developments
- 6.14 Ceva
- 6.14.1 Ceva Company Information
- 6.14.2 Ceva Business Overview
- 6.14.3 Ceva Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Ceva Porcine Medicine and Vaccines Product Portfolio
- 6.14.5 Ceva Recent Developments
- 6.15 CAVAC
- 6.15.1 CAVAC Company Information
- 6.15.2 CAVAC Business Overview
- 6.15.3 CAVAC Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 CAVAC Porcine Medicine and Vaccines Product Portfolio
- 6.15.5 CAVAC Recent Developments
- 6.16 CAHIC
- 6.16.1 CAHIC Company Information
- 6.16.2 CAHIC Business Overview
- 6.16.3 CAHIC Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 CAHIC Porcine Medicine and Vaccines Product Portfolio
- 6.16.5 CAHIC Recent Developments
- 6.17 Boehringer Ingelheim
- 6.17.1 Boehringer Ingelheim Company Information
- 6.17.2 Boehringer Ingelheim Business Overview
- 6.17.3 Boehringer Ingelheim Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio
- 6.17.5 Boehringer Ingelheim Recent Developments
- 6.18 Bioveta
- 6.18.1 Bioveta Company Information
- 6.18.2 Bioveta Business Overview
- 6.18.3 Bioveta Porcine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Bioveta Porcine Medicine and Vaccines Product Portfolio
- 6.18.5 Bioveta Recent Developments
7 North America
- 7.1 North America Porcine Medicine and Vaccines Market Size (2021-2032)
- 7.2 North America Porcine Medicine and Vaccines Market Size by Type
- 7.2.1 North America Porcine Medicine and Vaccines Market Size by Type (2021-2026)
- 7.2.2 North America Porcine Medicine and Vaccines Market Size by Type (2027-2032)
- 7.2.3 North America Porcine Medicine and Vaccines Market Share by Type (2021-2032)
- 7.3 North America Porcine Medicine and Vaccines Market Size by Application
- 7.3.1 North America Porcine Medicine and Vaccines Market Size by Application (2021-2026)
- 7.3.2 North America Porcine Medicine and Vaccines Market Size by Application (2027-2032)
- 7.3.3 North America Porcine Medicine and Vaccines Market Share by Application (2021-2032)
- 7.4 North America Porcine Medicine and Vaccines Market Size by Country
- 7.4.1 North America Porcine Medicine and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 7.4.3 North America Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 7.4.4 North America Porcine Medicine and Vaccines Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Porcine Medicine and Vaccines Market Size (2021-2032)
- 8.2 Europe Porcine Medicine and Vaccines Market Size by Type
- 8.2.1 Europe Porcine Medicine and Vaccines Market Size by Type (2021-2026)
- 8.2.2 Europe Porcine Medicine and Vaccines Market Size by Type (2027-2032)
- 8.2.3 Europe Porcine Medicine and Vaccines Market Share by Type (2021-2032)
- 8.3 Europe Porcine Medicine and Vaccines Market Size by Application
- 8.3.1 Europe Porcine Medicine and Vaccines Market Size by Application (2021-2026)
- 8.3.2 Europe Porcine Medicine and Vaccines Market Size by Application (2027-2032)
- 8.3.3 Europe Porcine Medicine and Vaccines Market Share by Application (2021-2032)
- 8.4 Europe Porcine Medicine and Vaccines Market Size by Country
- 8.4.1 Europe Porcine Medicine and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 8.4.3 Europe Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 8.4.4 Europe Porcine Medicine and Vaccines Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Porcine Medicine and Vaccines Market Size (2021-2032)
- 9.2 China Porcine Medicine and Vaccines Market Size by Type
- 9.2.1 China Porcine Medicine and Vaccines Market Size by Type (2021-2026)
- 9.2.2 China Porcine Medicine and Vaccines Market Size by Type (2027-2032)
- 9.2.3 China Porcine Medicine and Vaccines Market Share by Type (2021-2032)
- 9.3 China Porcine Medicine and Vaccines Market Size by Application
- 9.3.1 China Porcine Medicine and Vaccines Market Size by Application (2021-2026)
- 9.3.2 China Porcine Medicine and Vaccines Market Size by Application (2027-2032)
- 9.3.3 China Porcine Medicine and Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Porcine Medicine and Vaccines Market Size (2021-2032)
- 10.2 Asia Porcine Medicine and Vaccines Market Size by Type
- 10.2.1 Asia Porcine Medicine and Vaccines Market Size by Type (2021-2026)
- 10.2.2 Asia Porcine Medicine and Vaccines Market Size by Type (2027-2032)
- 10.2.3 Asia Porcine Medicine and Vaccines Market Share by Type (2021-2032)
- 10.3 Asia Porcine Medicine and Vaccines Market Size by Application
- 10.3.1 Asia Porcine Medicine and Vaccines Market Size by Application (2021-2026)
- 10.3.2 Asia Porcine Medicine and Vaccines Market Size by Application (2027-2032)
- 10.3.3 Asia Porcine Medicine and Vaccines Market Share by Application (2021-2032)
- 10.4 Asia Porcine Medicine and Vaccines Market Size by Country
- 10.4.1 Asia Porcine Medicine and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 10.4.3 Asia Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 10.4.4 Asia Porcine Medicine and Vaccines Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Type
- 11.2.1 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Porcine Medicine and Vaccines Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Application
- 11.3.1 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Porcine Medicine and Vaccines Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Country
- 11.4.1 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Porcine Medicine and Vaccines Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst